Aisling Capital is a leading investment firm that invests in companies developing and commercializing important and innovative healthcare products, services and technologies.

Meet Our Team

A combined 150+ years of experience in the healthcare industry.

learn more

See Our Portfolio

$1.6 billion in assets, with a track record of investing and returning capital since 2000.

learn more

Latest News

FDA permits marketing of new laser-based hearing aid with potential for broad sound amplification

September 29, 2015
The U.S. Food and Drug Administration today allowed marketing of a new hearing aid that uses a laser diode and direct vibration of the eardrum to amplify sound. The combination…

ZELTIQ(R) Receives FDA Clearance to Treat Submental Fat With Coolsculpting(R) Procedure

September 23, 2015
Introduction of New CoolMini(TM) Applicator Uniquely Designed to Non-Invasively Treat Smaller Pockets of Fat PLEASANTON, CA -- (Marketwired) -- 09/23/15 -- ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company…

Chimerix Presents New Research on Hospital Readmission Rates in Hematopoietic Cell Transplant Recipients

September 21, 2015
Opportunistic Infections Caused by dsDNA Viruses Occur Early in the Post-Transplant Period and Support Need for Preventive Therapies DURHAM, N.C., Sept. 21, 2015 (GLOBE NEWSWIRE) -- Chimerix, Inc. (NASDAQ:CMRX), a…